Actinium Pharmaceuticals, Inc. (FRA:7AY1)
Germany
· Delayed Price · Currency is EUR 1.214
-0.036 (-2.88%)
Last updated: Dec 5, 2025, 8:04 AM CET
Actinium Pharmaceuticals Revenue
Actinium Pharmaceuticals had revenue of $90.00K USD in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $90.00K, up 11.11% year-over-year.
Revenue (ttm)
$90.00K
Revenue Growth
+11.11%
P/S Ratio
499.91
Revenue / Employee
$2.43K
Employees
37
Market Cap
38.35M EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |